HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
CCCR News & Announcements
1 - 10 of 109
Scientists from Children’s Hospital of Philadelphia attend the American Society of Cell & Gene Therapy Annual Meeting to share their expertise through posters, panel discussions, and workshops.
Two recent papers from CHOP cancer researchers have advanced the understanding of treatment-resistant pediatric central nervous system tumors.
Learn about a technique to analyze large datasets, preclinical results that show safety and efficacy of a drug that could help children with high-risk neuroblastoma, and a milestone in the CORSICA project that seeks to cure rare sinonasal cancers.
We’re celebrating Women’s History Month by highlighting 10 women working in STEM fields who were nominated by their Center of Emphasis leaders.
By studying the molecular basis of pediatric thyroid cancer, Dr. Franco seeks to improve outcomes and quality of life for patients.
In this Q&A, Drs. Teachey and Diorio discuss their partnership and research of a novel CAR T-cell therapy for one of the most common pediatric cancers.
These six Cornerstone stories garnered the most engagements from our CHOP Research Twitter, Facebook, and LinkedIn channels.
This week's news roundup features an outstanding science award, Highly Cited Researchers, and STAT Wunderkinds, along with new research about cancer risk with birth defects, epilepsy, and acute myeloid leukemia.
In The News: Philadelphia Marathon, Adolescent Mental Health, C. difficile, Natural Language Processing, High-Risk Neuroblastoma
The work of Children’s Hospital of Philadelphia researchers leads to novel findings and recognitions.
CHOP Researchers Show Liquid Biopsies Can Catch Disease Progression Early in High-Risk Neuroblastoma
Liquid biopsies can less invasively and more accurately identify tumor changes in patients with high-risk neuroblastoma.